NASDAQ: SVRE
Saverone 2014 Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their SVRE stock forecasts and price targets.

Forecast return on equity

Is SVRE forecast to generate an efficient return?

Company
-39,948.3%
Industry
18.04%
Market
76.96%
SVRE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SVRE forecast to generate an efficient return on assets?

Company
-17,828.97%
Industry
10.9%
SVRE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SVRE earnings per share forecast

What is SVRE's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$11.78
Avg 2 year Forecast
-$10.23

SVRE revenue forecast

What is SVRE's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$2.5M+47.47%
Avg 2 year Forecast
$5.1M+204.63%
SVRE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SVRE revenue growth forecast

How is SVRE forecast to perform vs Scientific & Technical Instruments companies and vs the US market?

Company
47.47%
Industry
3.34%
Market
59.56%
SVRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SVRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SVRE vs Scientific & Technical Instrument Stocks

TickerPricePrice TargetUp/downsideConsensus
SVRE$2.01N/AN/A
WATT$0.25N/AN/A
SOBR$3.19N/AN/A
ELSE$4.17N/AN/A
FCUV$4.02N/AN/A

Saverone 2014 Stock Forecast FAQ

What is SVRE's earnings growth forecast for 2025-2026?

(NASDAQ: SVRE) Saverone 2014's forecast annual earnings growth rate of N/A is not forecast to beat the US Scientific & Technical Instruments industry's average forecast earnings growth rate of 30.86%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Saverone 2014's earnings in 2025 is -$34,938,000.On average, 1 Wall Street analyst forecast SVRE's earnings for 2025 to be -$4,889,914,235, with the lowest SVRE earnings forecast at -$4,889,914,235, and the highest SVRE earnings forecast at -$4,889,914,235.

In 2026, SVRE is forecast to generate -$4,246,504,467 in earnings, with the lowest earnings forecast at -$4,246,504,467 and the highest earnings forecast at -$4,246,504,467.

If you're new to stock investing, here's how to buy Saverone 2014 stock.

What is SVRE's revenue growth forecast for 2025-2026?

(NASDAQ: SVRE) Saverone 2014's forecast annual revenue growth rate of 47.47% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 3.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.

Saverone 2014's revenue in 2025 is $1,683,000.On average, 1 Wall Street analysts forecast SVRE's revenue for 2025 to be $1,030,285,835, with the lowest SVRE revenue forecast at $1,030,285,835, and the highest SVRE revenue forecast at $1,030,285,835.

In 2026, SVRE is forecast to generate $2,128,233,471 in revenue, with the lowest revenue forecast at $2,128,233,471 and the highest revenue forecast at $2,128,233,471.

What is SVRE's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: SVRE) forecast ROA is -17,828.97%, which is lower than the forecast US Scientific & Technical Instruments industry average of 10.9%.

What is SVRE's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: SVRE) Saverone 2014's current Earnings Per Share (EPS) is -$27.00. On average, analysts forecast that SVRE's EPS will be -$11.78 for 2025, with the lowest EPS forecast at -$11.78, and the highest EPS forecast at -$11.78. In 2026, SVRE's EPS is forecast to hit -$10.23 (min: -$10.23, max: -$10.23).

What is SVRE's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: SVRE) forecast ROE is -39,948.3%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.